Enzo Biochem, Inc. (ENZ)
NYSE$0.461
Market Cap
$24.08M
Sector
Healthcare
Industry
Medical—Diagnostics & Research
Rank in Sector
578 of 924
Rank in Industry
30 of 49
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
ENZ Insider Trading Activity
ENZ Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Related Transactions
No records found
About Enzo Biochem, Inc.
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. The Life Sciences Products segment develops, manufactures, and markets products and tools to clinical research, drug development, and bioscience research customers. It offers proteins, antibodies, …
Insider Activity of Enzo Biochem, Inc.
Over the last 12 months, insiders at Enzo Biochem, Inc. have bought $0 and sold $0 worth of Enzo Biochem, Inc. stock.
On average, over the past 5 years, insiders at Enzo Biochem, Inc. have bought $763,269 and sold $2.09M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 10,000 shares for transaction amount of $12,875 was made by Wolf James G. () on 2023‑02‑13.
List of Insider Buy and Sell Transactions, Enzo Biochem, Inc.
| 2023-02-13 | Wolf James G. | 10,000 0.0208% | $1.29 | $12,875 | +11.21% | |||
| 2023-02-10 | Wolf James G. | 5,000 0.0103% | $1.29 | $6,450 | +9.32% | |||
| 2023-01-27 | Wolf James G. | director | 11,800 0.024% | $1.40 | $16,520 | 0.00% | ||
| 2022-11-23 | Erfanian Hamid | Chief Executive Officer | 100,000 0.2052% | $1.97 | $197,000 | -23.61% | ||
| 2022-11-01 | Wolf James G. | director | 8,500 0.0172% | $2.14 | $18,225 | -28.79% | ||
| 2022-10-31 | Wolf James G. | director | 14,500 0.0299% | $2.15 | $31,175 | -27.69% | ||
| 2022-07-15 | Cannon Kara | Chief Operating Officer | 2,500 0.0052% | $2.42 | $6,050 | -9.13% | ||
| 2022-07-12 | Radoff Bradley Louis | 12,500 0.0243% | $2.27 | $28,375 | -9.13% | |||
| 2022-07-05 | Radoff Bradley Louis | 120,000 0.2362% | $2.20 | $264,000 | -4.76% | |||
| 2022-06-15 | Radoff Bradley Louis | 75,000 0.1523% | $2.20 | $165,000 | -0.99% | |||
| 2022-06-15 | Erfanian Hamid | Chief Executive Officer | 4,600 0.0093% | $2.19 | $10,074 | -0.99% | ||
| 2022-06-14 | Bench David | Chief Financial Officer | 3,500 0.0074% | $2.15 | $7,525 | +4.69% | ||
| 2021-03-16 | Sale | HARBERT MANAGEMENT CORP | 10 percent owner | 300,000 0.706% | $4.65 | $1.39M | -19.62% | |
| 2021-03-15 | Sale | HARBERT MANAGEMENT CORP | 10 percent owner | 144,768 0.4879% | $4.83 | $698,840 | +10.74% | |
| 2020-02-18 | CLEMENS PETER J IV | 10 percent owner | 4,000 0.0082% | $2.20 | $8,800 | +7.35% | ||
| 2020-02-14 | CLEMENS PETER J IV | 10 percent owner | 6,000 0.0125% | $2.21 | $13,260 | +7.39% | ||
| 2019-08-20 | HARBERT MANAGEMENT CORP | 10 percent owner | 9,700 0.0202% | $3.11 | $30,167 | -16.08% | ||
| 2019-08-16 | HARBERT MANAGEMENT CORP | 10 percent owner | 22,800 0.0456% | $3.06 | $69,768 | -18.37% | ||
| 2019-07-23 | HARBERT MANAGEMENT CORP | 10 percent owner | 409,200 0.87% | $3.65 | $1.49M | -24.92% | ||
| 2019-07-22 | HARBERT MANAGEMENT CORP | 10 percent owner | 9,644 0.0201% | $3.64 | $35,104 | -26.49% |
Total: 84
Insider Historical Profitability
<0.0001%
| HARBERT MANAGEMENT CORP | 10 percent owner | 5175913 9.9072% | $2.39M | 8 | 2 | <0.0001% |
| Radoff Bradley Louis | 4194663 8.029% | $1.93M | 3 | 0 | <0.0001% | |
| Wolf James G. | 4100000 7.8478% | $1.89M | 5 | 0 | <0.0001% | |
| RABBANI ELAZAR | Chm of the Bd, CEO and Sec | 1848668 3.5385% | $852,235.95 | 2 | 3 | +1.07% |
| RABBANI SHAHRAM K | Treasurer, Secretary | 1828494 3.4999% | $842,935.73 | 1 | 5 | <0.0001% |
ENZ Institutional Investors: Active Positions
| Increased Positions | 19 | +39.58% | 1M | +9.74% |
| Decreased Positions | 16 | -33.33% | 265,839 | -2.1% |
| New Positions | 8 | New | 1M | New |
| Sold Out Positions | 7 | Sold Out | 48,002 | Sold Out |
| Total Postitions | 51 | +6.25% | 14M | +7.64% |
ENZ Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Harbert Fund Advisors, Inc. | $2,490.00 | 9.95% | 5.18M | 0 | 0% | 2024-12-31 |
| Renaissance Technologies Llc | $1,139.00 | 4.55% | 2.37M | -159,986 | -6.33% | 2024-12-31 |
| Vanguard Group Inc | $894.00 | 3.58% | 1.86M | -17,620 | -0.94% | 2024-12-31 |
| Blackrock, Inc. | $462.00 | 1.85% | 959,839 | +688 | +0.07% | 2024-12-31 |
| Mink Brook Asset Management Llc | $389.00 | 1.55% | 807,899 | +807,899 | New | 2024-12-31 |
| Geode Capital Management, Llc | $177.00 | 0.71% | 367,093 | -1,553 | -0.42% | 2024-12-31 |
| Dimensional Fund Advisors Lp | $142.00 | 0.57% | 295,677 | -8,815 | -2.9% | 2024-12-31 |
| Rbf Capital, Llc | $120.00 | 0.48% | 250,359 | 0 | 0% | 2024-12-31 |
| Wittenberg Investment Management, Inc. | $90.00 | 0.36% | 187,537 | +70,400 | +60.1% | 2024-12-31 |
| Bridgeway Capital Management, Llc | $85.00 | 0.34% | 177,200 | -3,600 | -1.99% | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
No data is available at this moment.
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.